Toulouse, France

Julien Gilbert Jacques Malassis

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Julien Gilbert Jacques Malassis

Introduction

Julien Gilbert Jacques Malassis is a notable inventor based in Toulouse, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. With a total of two patents to his name, Malassis is recognized for his work in the pharmaceutical industry.

Latest Patents

Malassis's latest patents focus on a DNA polymerase theta inhibitor for the treatment of cancer. The present invention relates to a compound that inhibits Polθ, which is implicated in various diseases and conditions, particularly cancer. This novel therapeutic compound is useful for the treatment and prevention of such diseases. Additionally, the invention includes pharmaceutical compositions comprising the therapeutic compound, processes for synthesizing the compound, and their applications in treating conditions associated with Polθ activity.

Career Highlights

Julien Gilbert Jacques Malassis is currently associated with Breakpoint Therapeutics GmbH, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.

Collaborations

Some of his notable coworkers include Andrea Guerrero Corella and Stuart Robert Flanagan, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Julien Gilbert Jacques Malassis exemplifies the spirit of innovation in the pharmaceutical field, particularly in cancer treatment. His contributions through patents and collaborative work highlight the importance of research in developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…